A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bridgewater Associates, LP holds 46,700 shares of BDX stock, worth $10.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
46,700
Previous 210,340 77.8%
Holding current value
$10.7 Million
Previous $49.2 Million 77.1%
% of portfolio
0.07%
Previous 0.26%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $36.2 Million - $39.7 Million
-163,640 Reduced 77.8%
46,700 $11.3 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $8.91 Million - $9.75 Million
-39,594 Reduced 15.84%
210,340 $49.2 Million
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $10.9 Million - $11.6 Million
-46,853 Reduced 15.79%
249,934 $61.8 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $11.8 Million - $13.6 Million
-50,906 Reduced 14.64%
296,787 $72.4 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $4.77 Million - $5.31 Million
18,708 Added 5.69%
347,693 $89.9 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $11 Million - $12.2 Million
-45,945 Reduced 12.25%
328,985 $86.9 Million
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $2.38 Million - $2.69 Million
10,372 Added 2.85%
374,930 $92.8 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $7.89 Million - $9.29 Million
-36,142 Reduced 9.02%
364,558 $92.7 Million
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $2.39 Million - $12.4 Million
-46,895 Reduced 10.48%
400,700 $89.3 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $13.2 Million - $15.5 Million
-56,302 Reduced 11.17%
447,595 $110 Million
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $35.4 Million - $39.3 Million
145,116 Added 40.45%
503,897 $134 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $13.9 Million - $15.2 Million
60,575 Added 20.31%
358,781 $90.2 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $11.8 Million - $13 Million
50,739 Added 20.5%
298,206 $73.3 Million
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $12.2 Million - $13.4 Million
52,457 Added 26.9%
247,467 $60.2 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $11.3 Million - $12.5 Million
48,725 Added 33.31%
195,010 $47.4 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $17.2 Million - $19.1 Million
77,576 Added 112.91%
146,285 $36.6 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $14.8 Million - $19 Million
68,709 New
68,709 $16 Million
Q2 2020

Aug 12, 2020

SELL
$219.9 - $263.41 $1.87 Million - $2.24 Million
-8,509 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$195.69 - $279.01 $1.67 Million - $2.37 Million
8,509 New
8,509 $1.96 Million
Q4 2017

Feb 13, 2018

SELL
$189.0 - $222.64 $3.63 Million - $4.28 Million
-19,207 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $3.59 Million - $3.82 Million
19,207
19,207 $3.76 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.